Westborg I, Al-Najjar A, Norberg H
BMJ Open. 2025; 15(2):e089801.
PMID: 39909510
PMC: 11800199.
DOI: 10.1136/bmjopen-2024-089801.
Yuan Z, Vaughan S, Jeffcoat C, Hu P, Yuson R, Fife D
PLoS One. 2025; 20(1):e0313497.
PMID: 39787060
PMC: 11717312.
DOI: 10.1371/journal.pone.0313497.
Kunzmann B, Schweig A, Bartz-Schmidt K, Sobolewska B
Clin Ophthalmol. 2025; 18:4029-4039.
PMID: 39749039
PMC: 11694016.
DOI: 10.2147/OPTH.S482948.
Trivedi V, Lee S, Lee P, Me R, You Q, Im J
Clin Ophthalmol. 2024; 18:3949-3955.
PMID: 39737363
PMC: 11683196.
DOI: 10.2147/OPTH.S486044.
Singh R, Tabano D, Kuo B, LaPrise A, Leng T, Kim E
BMC Ophthalmol. 2024; 24(1):552.
PMID: 39736584
PMC: 11684133.
DOI: 10.1186/s12886-024-03797-9.
Dealing with the Verteporfin Shortage: Treatment Options and Outcomes in Patients with Chronic and Non-Resolving Central Serous Chorioretinopathy.
van den Tillaart F, Hartgers F, Hoyng C, Yzer S
Ophthalmologica. 2024; 248(1):11-21.
PMID: 39447560
PMC: 11901414.
DOI: 10.1159/000542224.
Treatment of Diabetic Macular Edema with Cycles of Three Injections of Anti-vascular Endothelial Growth Factor Injections.
Rehmani A, Banaee T, Alwan S, Urias E, Lyons L, El-Annan J
Middle East Afr J Ophthalmol. 2024; 30(3):141-148.
PMID: 39444996
PMC: 11495293.
DOI: 10.4103/meajo.meajo_17_22.
Multifocal Electroretinography Changes after UBX1325 (Foselutoclax) Treatment in Neovascular Age-Related Macular Degeneration.
Macha N, Yu M, Sapieha P, Klier S, Ghosh A, White L
J Clin Med. 2024; 13(18).
PMID: 39337030
PMC: 11433175.
DOI: 10.3390/jcm13185540.
Retrospective Large Database Study of Central Serous Chorioretinopathy Treatments and Visual Outcomes Analysis in the United States.
Burgett L, Aggarwal N, Latona J, Driban M, Chhablani J, Maturi R
J Vitreoretin Dis. 2024; 8(5):508-516.
PMID: 39318981
PMC: 11418707.
DOI: 10.1177/24741264241257021.
[Aflibercept in the clinical routine: the AURIGA study : The 24-month results of the German cohort of treatment-naïve patients with diabetic macular edema receiving intravitreal aflibercept].
Ulbig M, Brinkmann C, Mirshahi A, Hoerauf H, Allmeier H, Machewitz T
Ophthalmologie. 2024; 121(11):894-903.
PMID: 39287660
DOI: 10.1007/s00347-024-02110-9.
PREDNISOLONE EYE DROPS AS A POTENTIAL TREATMENT IN NONNEOVASCULAR PACHYCHOROID-RELATED DISEASES.
van den Tillaart F, Temmerman I, Hartgers F, Yzer S
Retina. 2024; 44(8):1371-1378.
PMID: 39047197
PMC: 11280446.
DOI: 10.1097/IAE.0000000000004109.
Comparing the efficacy of dexamethasone implant and anti-VEGF for the treatment of macular edema: A systematic review and meta-analysis.
Tang H, Li J, Yuan Y, Ling Y, Mei Z, Zou H
PLoS One. 2024; 19(7):e0305573.
PMID: 38985778
PMC: 11236136.
DOI: 10.1371/journal.pone.0305573.
[Aflibercept in a real-world setting: the AURIGA study : 24-month results of the German cohort of treatment-naïve patients with macular edema following retinal vein occlusion receiving intravitreal aflibercept].
Wachtlin J, Kaymak H, Hoerauf H, Allmeier H, Machewitz T, Scholz P
Ophthalmologie. 2024; 121(8):650-657.
PMID: 38976039
DOI: 10.1007/s00347-024-02051-3.
Comparison of Methods of Clinical Trial Emulation Utilizing Data From the Comparison of AMD Treatment Trial (CATT) and the IRIS® Registry.
Fevrier H, LaPrise A, Mbagwu M, Leng T, Torres A, Borkar D
Ophthalmol Sci. 2024; 4(5):100524.
PMID: 38881608
PMC: 11179401.
DOI: 10.1016/j.xops.2024.100524.
Comparative efficacy of anti-vascular endothelial growth factor on diabetic macular edema diagnosed with different patterns of optical coherence tomography: A network meta-analysis.
Yao J, Huang W, Gao L, Liu Y, Zhang Q, He J
PLoS One. 2024; 19(6):e0304283.
PMID: 38848379
PMC: 11161126.
DOI: 10.1371/journal.pone.0304283.
Effect of Race and Insurance Status on Treatment and Outcomes in Diabetic Retinopathy: Analysis of 43 274 Eyes Using the IRIS Registry.
Maturi J, Maturi V, Scott A, Carson K, Ciulla T, Maturi R
J Vitreoretin Dis. 2024; 8(3):270-279.
PMID: 38770080
PMC: 11102718.
DOI: 10.1177/24741264231221607.
Treatment Outcomes of Intravitreal Aflibercept for Uveitic Macular Edema.
Oyeniran E, Bhandari S, Amir A, Soifer M, Bellur S, Vitale S
Ocul Immunol Inflamm. 2024; :1-8.
PMID: 38759221
PMC: 11569270.
DOI: 10.1080/09273948.2024.2344709.
Visual Tracking in Amblyopia: A Continuous Psychophysical Approach.
Li C, Yang Y, Zhu J, Han Y, He J, Wang J
Invest Ophthalmol Vis Sci. 2024; 65(5):7.
PMID: 38700875
PMC: 11078166.
DOI: 10.1167/iovs.65.5.7.
The characteristics of white dot syndromes following COVID-19 Vaccines: a systematic review.
Abu Serhan H, Abu Suilik H, Hassan A, AlSamhori J, Hassan A, Siddiq A
Int Ophthalmol. 2024; 44(1):189.
PMID: 38652153
PMC: 11039548.
DOI: 10.1007/s10792-024-03119-4.
The Reinforced Treat-and-Extend Protocol for Exudative Age-Related Macular Degeneration: Retrospective Assessment of 24-Month Real-World Outcomes in France.
Roubelat F, Barioulet L, Varenne F, Escudier C, Meyer P, Gomane C
Ophthalmol Ther. 2024; 13(6):1647-1667.
PMID: 38625500
PMC: 11109064.
DOI: 10.1007/s40123-024-00938-7.